Primary Record
Firsocostat
Note: Only for scientific research or as raw materials for production.
- In stock
- 7,773 g
- Purity
- 98.6 %
- CAS
- 1434635-54-7
Compound Identifiers & Properties
- CAS
- 1434635-54-7
- PubChem CID
- 71528744
- SMILES
- CC1=C(SC2=C1C(=O)N(C(=O)N2C[C@@H](C3=CC=CC=C3OC)OC4CCOCC4)C(C)(C)C(=O)O)C5=NC=CO5
- Canonical SMILES
- COc1ccccc1[C@H](Cn1c(=O)n(C(C)(C)C(=O)O)c(=O)c2c(C)c(-c3ncco3)sc21)OC1CCOCC1
Names & Synonyms
- Firsocostat
- ND-630
- firsocostatum
- 1434635-54-7
- GS-ACC
- Firsocostat [USAN]
- XE10NJQ95M
- Firsocostat (GS-0976)
- RefChem:921616
- FIRSOCOSTAT [INN]
- Firsocostat (USAN/INN)
- NDI-010976
- GS-0976
- UNII-XE10NJQ95M
- FIRSOCOSTAT [WHO-DD]
- C28H31N3O8S
- orb1300001
- CHEMBL3407547
- SCHEMBL14945041
- SCHEMBL29539821
- Firsocostat(ND-630,GS-0976)
- GTPL10645
- ND 630
- ZZWWXIBKLBMSCS-FQEVSTJZSA-N
- DTXSID801358907
- AMY16826
- EX-A2586
- MFCD28963986
- ND 630;ND630
- s8893
- WHO 10738
- AKOS037648731
- ZINC207531097
- ACN-053192
- CS-6509
- AC-31460
- BS-15388
- HY-16901
- ND-630; NDI-010976; Firsocostat
- (R)-2-(1-(2-(2-methoxyphenyl)-2-((tetrahydro-2H-pyran-4-yl)oxy)ethyl)-5-methyl-6-(oxazol-2-yl)-2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl)-2-methylpropanoic acid
- J3.476.714I
- D11640
- A858139
- 2-[1-[(2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,4-dioxothieno[2,3-d]pyrimidin-3-yl]-2-methylpropanoic acid
- B0084-007342
- FIRSOCOSTAT ( ND-630; GS-0976; NDI-010976)
- 1,4-Dihydro-1-((2R)-2-(2-methoxyphenyl)-2-((tetrahydro-2H-pyran-4-yl)oxy)ethyl)-alpha,alpha,5-trimethyl-6-(2-oxazolyl)-2,4-dioxothieno(2,3-d)pyrimidine-3(2H)-acetic acid
- 2-(1-((2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl)-5-methyl-6-(1,3-oxazol-2-yl)-2,4-dioxothieno(2,3-d)pyrimidin-3-yl)-2-methylpropanoic acid
- 2-{1-[(2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,4-dioxo-1H,2H,3H,4H-thieno[2,3-d]pyrimidin-3-yl}-2-methylpropanoic acid
- 1,4-DIHYDRO-1-((2R)-2-(2-METHOXYPHENYL)-2-((TETRAHYDRO-2H-PYRAN-4-YL)OXY)ETHYL)-.ALPHA.,.ALPHA.,5-TRIMETHYL-6-(2-OXAZOLYL)-2,4-DIOXOTHIENO(2,3-D)PYRIMIDINE-3(2H)-ACETIC ACID
- 1,4-Dihydro-1-[(2R)-2-(2-methoxyphenyl)-2-[(tetrahydro-2H-pyran-4-yl)oxy]ethyl]-|A,|A,5-trimethyl-6-(2-oxazolyl)-2,4-dioxothieno[2,3-d]pyrimidine-3(2H)-acetic acid
- 2-[1-[(2R)-2-(2-methoxyphenyl)-2-tetrahydropyran-4-yloxy-ethyl]-5-methyl-6-oxazol-2-yl-2,4-dioxo-thieno[2,3-d]pyrimidin-3-yl]-2-methyl-propanoic acid
- 2-[1-[(R)-beta-[(Tetrahydro-2H-pyran-4-yl)oxy]-2-methoxyphenethyl]-2,4-dioxo-5-methyl-6-(oxazole-2-yl)-1,2-dihydrothieno[2,3-d]pyrimidine-3(4H)-yl]-2-methylpropanoic acid
- 2-{1-[(2R)-2-(2-METHOXYPHENYL)-2-(OXAN-4-YLOXY)ETHYL]-5-METHYL-6-(1,3-OXAZOL-2-YL)-2,4-DIOXOTHIENO[2,3-D]PYRIMIDIN-3-YL}-2-METHYLPROPANOIC ACID
- 2-Methyl-2-[1-[(R)-beta-[(tetrahydro-2H-pyran-4-yl)oxy]-2-methoxyphenethyl]-2,4-dioxo-5-methyl-6-(oxazole-2-yl)-1,2-dihydrothieno[2,3-d]pyrimidine-3(4H)-yl]propanoic acid
- THIENO(2,3-D)PYRIMIDINE-3(2H)-ACETIC ACID, 1,4-DIHYDRO-1-((2R)-2-(2-METHOXYPHENYL)-2-((TETRAHYDRO-2H-PYRAN-4-YL)OXY)ETHYL)-.ALPHA.,.ALPHA.,5-TRIMETHYL-6-(2-OXAZOLYL)-2,4-DIOXO-